Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 459852
                    [Title] => Statin reduces life-threatening leg vein clots
                    [Summary] => 
MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.
                    [DatePublished] => 2009-04-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 420530
                    [Title] => A new dimension to heart treatment
                    [Summary] => A study involving an anti-cholesterol drug revealed that risks of heart diseases were diminished even in people with low to normal cholesterol levels.
                    [DatePublished] => 2008-12-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 416474
                    [Title] => Results of landmark statin study revealed
                    [Summary] => In one of the hottest medical findings in the current year, the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Trial showed that statins could cut the risk of heart attack, stroke and cardiovascular death in apparently healthy individuals.
                    [DatePublished] => 2008-11-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

SCIENTIFIC SESSIONS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 459852
                    [Title] => Statin reduces life-threatening leg vein clots
                    [Summary] => 
MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.
                    [DatePublished] => 2009-04-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 420530
                    [Title] => A new dimension to heart treatment
                    [Summary] => A study involving an anti-cholesterol drug revealed that risks of heart diseases were diminished even in people with low to normal cholesterol levels.
                    [DatePublished] => 2008-12-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 416474
                    [Title] => Results of landmark statin study revealed
                    [Summary] => In one of the hottest medical findings in the current year, the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Trial showed that statins could cut the risk of heart attack, stroke and cardiovascular death in apparently healthy individuals.
                    [DatePublished] => 2008-11-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Statin reduces life-threatening leg vein clots

April 23, 2009 - 12:00am

MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.

Science and Environment

A new dimension to heart treatment

December 4, 2008 - 12:00am

A study involving an anti-cholesterol drug revealed that risks of heart diseases were diminished even in people with low to normal cholesterol levels.

Science and Environment

Results of landmark statin study revealed

November 20, 2008 - 12:00am

In one of the hottest medical findings in the current year, the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Trial showed that statins could...

Science and Environment